Psychologists in San Leandro, CA Accepting Medicare
46 Psychologists found. Showing 41 - 46
 Dr. Myron John Gulseth, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 13851 East 14th Street, Suite 203, San Leandro, CA 94578 Phone: 510-483-7100 Fax: 510-351-4328 |
 Dr. Loni L Fillmore, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2500 Merced St, San Leandro, CA 94577 Phone: 510-454-1000 |
Heli T Nikulainen, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 2060 Fairmont Dr, Jgpp, San Leandro, CA 94578 Phone: 510-346-1304 |
Mrs. Megan Erion, DOCTORAL CANDIDATE Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 2401 Merced St, San Leandro, CA 94577 Phone: 206-595-9523 |
Mariah Ann Howard Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3081 Teagarden St, San Leandro, CA 94577 Phone: 510-347-4620 |
Kambiz Sakhai, PSYD Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 303 W Joaquin Ave Ste 100, San Leandro, CA 94577 Phone: 510-689-6236 Fax: 510-373-6282 |
News Archive
New tool can help improve ultrasound treatment for soft tissue injuries
A new tool developed at the National Physical Laboratory (NPL), the UK's National Measurement Institute, could help improve the quality of ultrasound treatment for soft tissue injuries such as muscle strains and ligament damage.
Pro-Pharmaceuticals plans to submit Phase III trial design for DAVANAT to FDA
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced plans to submit a Phase III trial design for DAVANAT to the U.S. Food and Drug Administration during the second half of 2010. The Company has added the talent of Peter G. Traber, M.D., to its FDA approval strategy and trial design team.
AutoGenomics, Genomas sign agreement to develop DNA-guided diagnostic systems
AutoGenomics, Inc, a leader in automated microarray technology for molecular diagnostics, and Genomas, a biomedical company enabling DNA-guided medicine for personal healthcare, announced today that they have signed an agreement to jointly develop genetic tests and DNA-guided diagnostic systems for optimal selection of statins and for improved delivery of statin therapy for the treatment of cardiovascular disease, obesity and diabetes.
Senate Dems prepare contingency plans as finance negotiators grapple for a deal
"Senate Democrats may decide to pass a U.S. health-care overhaul without Republican support if some opposition lawmakers don't agree to a plan by mid-September," Senator Charles Schumer[ D-N.Y.] said" according to Bloomberg. Schumer said Sen. Max Baucus, D-Mont., set a self-imposed deadline of Sept. 15 to lead a negotiating team, composed of three Republicans and three Democrats within his Finance Committee, to a bipartisan compromise.
› Verified 6 days ago
Counselors
Clinical Social Workers
Dentists
Pharmacists
Occupational Therapists
Psychologists